AlloVir Inc

+0.29 (+3.81%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

AlloVir Inc Stock, NASDAQ:ALVR

1100 Winter Street, Suite 1274, Waltham, Massachusetts 02451
United States of America
Phone: +1.617.433.2605
Number of Employees: 107


AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.